Richard T. Cheney

University at Buffalo, State University of New York — United States

Medicine · Health Sciences

36h-index7.1kcitations88works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Nonmelanoma Skin Cancer Studies(9), Vascular Tumors and Angiosarcomas(9), Sarcoma Diagnosis and Treatment(8), Lung Cancer Treatments and Mutations(8), Lung Cancer Diagnosis and Treatment(7)

Publications88 total

Trends in Bone Marrow Sampling and Core Biopsy Specimen Adequacy in the United States and Canada
American Journal of Clinical Pathology·2018· 9 citedOpen Access
Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non–Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance)
Journal of Clinical Oncology·2017· 76 citedOpen Access
Final Results of a Phase 3 Trial of Celecoxib (C) in Addition to Standard Chemotherapy for Advanced Non–Small Cell Lung Cancer With COX- 2 Overexpression: CALGB 30801 (Alliance)
International Journal of Radiation Oncology*Biology*Physics·2017
NCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.2016
Journal of the National Comprehensive Cancer Network·2016· 103 citedOpen Access
Basal Cell Skin Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network·2016· 272 citedOpen Access
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 4.2016
Journal of the National Comprehensive Cancer Network·2016· 733 citedOpen Access
Non–Small Cell Lung Cancer, Version 6.2015
Journal of the National Comprehensive Cancer Network·2015· 487 cited
Homogenous Good Outcome in a Heterogeneous Group of Tumors: An Institutional Series of Outcomes of Superficial Soft Tissue Sarcomas
Sarcoma·2015· 7 citedOpen Access
Non–Small Cell Lung Cancer, Version 1.2015
Journal of the National Comprehensive Cancer Network·2014· 217 cited
Abstract CT238: Phase III randomized, placebo controlled trial of COX-2 inhibition in addition to standard chemotherapy for advanced non-small cell lung cancer (NSCLC):CALGB 30801 (Alliance)
Cancer Research·2014· 3 cited
Lymphangioma circumscriptum of the vulva in a patient with Noonan syndrome.
PubMed·2014· 6 cited
Dermatofibrosarcoma Protuberans, Version 1.2014
Journal of the National Comprehensive Cancer Network·2014· 41 citedOpen Access
Merkel Cell Carcinoma, Version 1.2014
Journal of the National Comprehensive Cancer Network·2014· 52 citedOpen Access
NCCN Guidelines Version 1.2015 Panel Members Non-Small Cell Lung Cancer
2014· 14 cited
Giant Keratoacanthoma
American Journal of Dermatopathology·2013· 15 cited
Non–Small Cell Lung Cancer, Version 2.2013
Journal of the National Comprehensive Cancer Network·2013· 448 cited
Thymomas and Thymic Carcinomas
Journal of the National Comprehensive Cancer Network·2013· 123 citedOpen Access
Non–Small Cell Lung Cancer
Journal of the National Comprehensive Cancer Network·2012· 359 citedOpen Access
Dermatofibrosarcoma Protuberans
Journal of the National Comprehensive Cancer Network·2012· 69 citedOpen Access
Radioguided Detection of Lymph Node Metastasis in Non-Small Cell Lung Cancer
Journal of Surgical Research·2012
page 1 of 5Next →

Frequent Co-authors

Karen L. Reckamp(10), David S. Ettinger(9), Douglas E. Wood(9), Lucian R. Chirieac(9), Thomas A. D’Amico(9), Ramaswamy Govindan(9), Thierry Jahan(9), Gregory A. Otterson(9), Jyoti D. Patel(9), Katherine M.W. Pisters(9), Gregory J. Riely(9), Hossein Borghaei(8), Billy W. Loo(8), Steven Swanson(8), Stephen C. Yang(8), Ritsuko Komaki(7), Kristina M. Gregory(7), Miranda Hughes(7), Todd L. Demmy(7), Frederic W. Grannis(7)